Health care businesses Medytox Solutions Inc. and CollabRx Inc. (Nasdaq: CLRX) are merging.

Medytox, headquartered in West Palm Beach, Florida, owns clinical testing laboratories, an electronics records provider, a laboratory information systems company and a medical billing company. San Francisco-based CollabRx provides services to interpret molecular and genetic tests for cancer.

Under the terms of the deal, Medytox shareholders will own 90 percent of the new company, and CollabRX shareholders will own 10 percent. The companies expect the merger to speed up their growth.

For 2014, Medyotx had $57.9 million in revenue and $15.7 million in income, and CollabRx had $415,000 and a net loss of $4.3 million.

 Aegis Capital Corp. was CollabRx's financial adviser for the deal, while Goodwin Procter LLP provided legal advice. Akerman LLP provided legal advice to Medytox.

There has been a lot of M&A activity among companies that provide services to health care providers as they bulk up technology to handle an increased patient load from the Affordable Care Act. For more on the trend, see 5 Technologies That Drove Health Care M&A in 2014.

Other recent health care technology deals have come from KPMG, which bought health care consulting firm Beacon Partners earlier in April, and Digirad Corp. (Nasdaq: DRAD), which picked up mobile diagnostic imaging company MD Office Solutions in March. 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.